(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of 4.87% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.13%.
Iridex's revenue in 2026 is $52,578,000.On average, 3 Wall Street analysts forecast IRIX's revenue for 2026 to be $945,034,675, with the lowest IRIX revenue forecast at $907,958,792, and the highest IRIX revenue forecast at $972,815,478. On average, 3 Wall Street analysts forecast IRIX's revenue for 2027 to be $1,007,854,799, with the lowest IRIX revenue forecast at $968,342,003, and the highest IRIX revenue forecast at $1,037,498,099.
In 2028, IRIX is forecast to generate $1,066,880,301 in revenue, with the lowest revenue forecast at $1,025,035,032 and the highest revenue forecast at $1,098,264,253.